Progression of pancreatic neuroendocrine tumors (PanNETs) to metastatic disease is associated with MCT4 expression and metabolic heterogeneity

被引：0
|
作者：
Sadowski, M. [1 ]
Brautigam, K. [1 ]
Straub, J. [1 ]
Andreasi, V [2 ]
Kirchner, P. [1 ]
Maire, R. [1 ]
Dettmer, M. [1 ]
Schrader, J. [3 ]
Partelli, S. [2 ]
Falconi, M. [2 ]
Marinoni, I [1 ]
Perren, A. [1 ]
机构：
[1] Univ Bern, Bern, Switzerland
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2023年 / 35卷
关键词：
mct4; metabolic subtypes; aggressive pannet; patient-derived tumoroid;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F19
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [31] Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1
    Andreas Selberherr
    Oskar Koperek
    Philipp Riss
    Christian Scheuba
    Martin B. Niederle
    Reto Kaderli
    Aurel Perren
    Bruno Niederle
    Orphanet Journal of Rare Diseases, 14
  • [32] Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1
    Selberherr, Andreas
    Koperek, Oskar
    Riss, Philipp
    Scheuba, Christian
    Niederle, Martin B.
    Kaderli, Reto
    Perren, Aurel
    Niederle, Bruno
    ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [33] High proliferation is independently associated with disease progression in metastatic pancreatic adenocarcinoma
    Temraz, S.
    Hammoud, M. Salim
    Makki, I.
    Nassif, S.
    Charafeddine, M.
    Mukherji, D.
    Shamseddine, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [34] Expression and Epigenetic Regulation of E-cadherin in Metastatic Gastrointestinal and Pancreatic Neuroendocrine Tumors and Carcinomas
    Lamzabi, Ihab
    Buckingham, Lela
    Jain, Richa
    Barbanera, William
    Singh, Rohit
    Jakate, Shriram
    Gattuso, Paolo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 : 105 - 105
  • [35] Different Characteristics in Hormonal Expression Between Primary Pancreatic Neuroendocrine Tumors (PNETs) and Metastatic Sites
    Kimura, Hideyo
    Ohtsuka, Takao
    Fujimoto, Takaaki
    Date, Kenjiro
    Matsunaga, Taketo
    Watanabe, Yusuke
    Tamura, Koji
    Abe, Atsushi
    Mizuuchi, Yusuke
    Miyasaka, Yoshihiro
    Yamada, Daisuke
    Igarashi, Hisato
    Ito, Tetsuhide
    Takahata, Shunichi
    Oda, Yoshinao
    Mizumoto, Kazuhiro
    Tanaka, Masao
    GASTROENTEROLOGY, 2015, 148 (04) : S1171 - S1171
  • [36] Endocan Expression Is Correlated with Poor Progression-Free Survival in Patients with Pancreatic Neuroendocrine Tumors
    Lin, L. Y.
    Yeh, Y. C.
    Chu, C. H.
    Chen, M.
    NEUROENDOCRINOLOGY, 2018, 106 : 33 - 33
  • [37] ATRX Loss in Pancreatic Neuroendocrine Tumors Is Associated With Disease Recurrence and Decreased Survival
    Singhi, Aatur
    Lu, Ta-Chiang
    Ma, Changqing
    Cressman, Kristi
    Bahary, Nathan
    Zeh, Herbert
    Hogg, Melissa
    Zureikat, Amer
    LABORATORY INVESTIGATION, 2015, 95 : 449A - 449A
  • [38] Pancreatic neuroendocrine tumors associated with vonHippel Lindau disease: Diagnostic and management recommendations
    Libutti, SK
    Choyke, PL
    Bartlett, DL
    Vargas, H
    Walther, M
    Lubensky, I
    Glenn, G
    Linehan, WM
    Alexander, HR
    SURGERY, 1998, 124 (06) : 1153 - 1159
  • [39] ATRX Loss in Pancreatic Neuroendocrine Tumors Is Associated With Disease Recurrence and Decreased Survival
    Singhi, Aatur
    Lu, Ta-Chiang
    Ma, Changqing
    Cressman, Kristi
    Bahary, Nathan
    Zeh, Herbert
    Hogg, Melissa
    Zureikat, Amer
    MODERN PATHOLOGY, 2015, 28 : 449A - 449A
  • [40] Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors
    Lin, Liang-Yu
    Yeh, Yi-Chen
    Chu, Chia-Huei
    Won, Justin G. S.
    Shyr, Yi-Ming
    Chao, Yee
    Li, Chung-Pin
    Wang, Shin-E
    Chen, Ming-Huang
    MEDICINE, 2017, 96 (41)
12345